NCT05280236View on ClinicalTrials.gov

Comparison of Quality of Recovery Between Remimazolam and Propofol Anesthesia in Patients Undergoing Arthroscopic Meniscectomy

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 14, 2022

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions
Adult Patients 19 or Older Scheduled for Elective Arthroscopic Meniscectomy
Interventions
DRUG

Propofol TIVA

Patients will receive propofol-based TIVA with propofol and remifentanil TCI (target controlled infusion)

DRUG

Remimazolam TIVA

Patients will receive remimazolam-based TIVA with remimazolam infusion and remifentanil TCI

Trial Locations (1)

Unknown

Yonsei University Health System, Severance Hospital, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER